Alex Sapir, See Remarks at Fulcrum Therapeutics, Inc. (FULC), bought 43,360 shares at $11.35 ($492K) on 2024-03-04, disclosed to the SEC on 2024-03-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |